| |
| |
| |
| |
| |
核心数字 |
中国大陆（7.3）:
确证病例:5327
新增 确证病例:0
死亡病例:348
新增死亡病例:0
治愈病例:4933
新增治愈人数:0
死亡率:6.5%
治愈率: 92.6% |
北京（7.3）:
确证病例:2521
新增确证病例:0
死亡病例:192
新增死亡病例:0
治愈病例:2295
新增治愈人数:0
死亡率: 7.6%
治愈率: 91.0% |
| 北京18区县每日疫情统计 |
香港（7.3）:
确证病例:1755
新增确证病例:0
死亡病例:298
新增 死亡病例:0
治愈病例:1429
新增治愈人数:0
死亡率:17.0%
治愈率: 81.4% |
台湾（7.2）:
确证病例:676
新增确证病例:0
死亡病例:84 |
统计图表（6.30）【CMBI】:
确证病例态势图
死亡病例态势图
治愈病例态势图
死亡率态势图
治愈率态势图
日增确证感染病例态势图
日增死亡病例态势图
日增治愈病例态势图
|
|
|
| |
| 沉着应对、措施果断
依靠科学、有效防治
加强合作、完善机制 |
|
---中共中央政治局
|
|
|
|
| |
北京市血液中心公布非典康复者血浆捐献电话:
62031992 |
|
| |
| 推荐分辨率:1024#768 |
| |
| |
|
| |
| |
| |
|
|
| |
|
| |
| 最 新 科 学 文 献 |
Sort
by Classify |
此栏目主要收录国际最新的SARS相关文献，国内文献请参阅万方数据和CNKI
- SARS综述:SARS病毒基因组与侵入宿主细胞研究近况－幻灯片(CMBI－版本
5.16)update
- SARS综述:SARS非典型肺炎的临床和治疗进展－幻灯片(CMBI－版本
5.21)update
- The Preliminary
Analysis of SARS Co-V-Host Cell Interaction(CMBI-PUCHG
Since 5.7)
- The Preliminary
Analysis of SARS Coronavirus Genome and Proteins(CMBI-PUCHG
Since 4.26)
- Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience(CMAJ－2004.1.6)
- Laboratory tests for SARS: Powerful or peripheral?(CMAJ－2004.1.6)
- Severe acute respiratory syndrome (SARS)—paradigm of an emerging viral infection(J Clin Virology－2004,vol29)
- Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase(JBC－2004.1)
- Evaluation of Control Measures Implemented in the Severe Acute Respiratory Syndrome Outbreak in Beijing,2003(JAMA－12.24)
- Interferon Alfacon-1 plus Corticosteroids in Severe Acute Respiratory Syndrome(JAMA－12.24)
- Early diagnosis of SARS Coronavirus infection by real time RT-PCR(J Clin Virology－2003,vol28)
- Severe Acute Respiratory Syndrome (SARS)-Editorial(J Clin Virology－2003,vol28)
- SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients(J Clin Virology－2003,vol28)
- SARS virus infection of cats and ferrets(Nature－10.30)
- Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus(PNAS－10.28)
- Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China(Science－10.10)
- Isolation and Characterization
of Viruses Related to the SARS Coronavirus from Animals in Southern
China(Sciencexpress－9.4)
- Possible role of an animal
vector in the SARS outbreak at Amoy Gardens(Lancet－8.16)
- Managing SARS (N Engl
J Med－8.14)
- SARS in Hong Kong (N
Engl J Med－8.14)
- SARS and the Internet (N
Engl J Med－8.14)
- A surfeit of SARS (Lancet－8.12)
- SARS: Epidemiology,
Clinical Presentation, Management, and Infection Control Measures(Mayo
Clin Proc－7)
- SARS: 1918 Revisited? The
Urgent Need for Global Collaboration in Public Health(Mayo
Clin Proc－7)
- Fatal Aspergillosis in a
Patient with SARS Who Was Treated with Corticosteroids (N
Engl J Med－7.31)
- Profile of Specific Antibodies
to the SARS-Associated Coronavirus (N Engl J Med－7.31)
- Newly discovered coronavirus
as the primary cause of severe acute respiratory syndrome(Lancet－7.26)
- Treatment of SARS with human
interferons (Lancet－7.26)
- SARS — Looking Back over
the First 100 Days (N Engl J Med－7.24)
- SARS Reference(SARSReference－7.10)
- SARS, What have we
learned? (Nature－7.10)
- Coronavirus Genomic-Sequence
Variations and the Epidemiology of the Severe Acute Respiratory
Syndrome(N Engl J Med－7.10)
- Evaluation
of WHO criteria for identifying patients with severe acute respiratory
syndrome out of hospital: prospective observational study(BMJ－6.21)
- Haematological manifestations
in patients with severe acute respiratory syndrome: retrospective
analysis(BMJ－6.21)
- SARS: Threat of tuberculosis
persists(BMJ－6.21)
- SARS:Lessons may be learnt
from the outbreak of legionnaires' disease in Barrow in Furness
(BMJ－6.21)
- SARS:Capture-recapture
method should be used to count how many cases of SARS really exist
(BMJ－6.21)
- SARS:Numbers do not tell
whole story (BMJ－6.21)
- SARS:Guidelines were
drawn up collaboratively to protect healthcare workers in British
Columbia(BMJ－6.21)
- SARS: Private hospital
in Singapore took effective control measures (BMJ－6.21)
- SARS:Clinical outcome
after inpatient outbreak of SARS in Singapore (BMJ－6.21)
- Transmission Dynamics
and Control of Severe Acute Respiratory Syndrome (Science－6.20)
- Transmission Dynamics
of the Etiological Agent of SARS in Hong Kong: Impact of Public
Health Interventions (Science－6.20)
- A new infectious disease
challenge: Urbani severe acute respiratory syndrome (SARS) associated
coronavirus(Immunology－6.16)
- Glycyrrhizin, an active
component of liquorice roots, and replication of SARS-associated
coronavirus(Lancet－6.14)
- SARS genome patent: symptom
or disease?(Lancet－6.14)
- Coronavirus Main
Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs(Science－6.13)
- Updated SARS case definition
using laboratory criteria(JAMC－6.10)
- A 3D model of SARS_CoV
3CL proteinase and its inhibitors design by virtual screening(Acta
Pharmacol Sin－6.10)
- Small envelope protein
E of SARS: cloning, expression, purification, CD determination,
and bioinformatics analysis1(Acta Pharmacol Sin－6.10)
- Clinical Features and Short-term
Outcomes of 144 Patients with SARS in the Greater Toronto Area(JAMA－6.4)
- SARS Providing Care in
the Face of Uncertainty(JAMA－6.4)
- Hiding in the Bunker: Challenges
for a radiation oncology department operating in the Severe Acute
Respiratory Syndrome outbreak(Australas Radiol－6.3)
- Severe Acute Respiratory
Syndrome (SARS) in Singapore- Clinical Features of Index Patient
and Initial Contacts (Emerging Infectious Diseases－6.3)
- Control Measures for Severe
Acute Respiratory Syndrome in Taiwan(Emerging Infectious
Diseases－6.3)
- SARS_Cov刺突蛋白入侵宿主细胞的机制假说模型(温州师范学院生命与环境科学学院－陈银道、赵敏)(CMBI－6.3)
- WHO is SARS?(Lancet
Infectious Diseases－6.1)
- SARS sequencing paves the
way for better diagnostics(Lancet Infectious Diseases－6.1)
- Severe acute respiratory
syndrome in developing countries(Lancet Infectious Diseases－6.1)
- Web serves as conduit for
SARS information(Lancet Infectious Diseases－6.1)
- SARS coronavirus: a new
challenge for prevention and therapy(J Clin Invest－6.1)
- SARS病原学的确立(北大医学部微生物学系－彭宜红、朱永红)(CMBI－6.1)
- Heroes, SARS, staffing,
and family presence(J Emerg Nurs－6.1)
- The SARS Coronavirus:A
Postgenomic Era (Science－5.30)
- The Genome Sequence
of the SARS-Associated Coronavirus(Science－5.30)
- Mass Spectrometric Characterization
of Proteins from the SARS Virus: a Preliminary Report(Mol
Cell Proteomics－5.29)
- Challenging beliefs and
ethical concepts: the collateral damage of SARS(Critical
Care－5.29)
- Novel Therapies Based on
Mechanisms of HIV-1 Cell Entry(NEJM－5.29)--编者按：HIV与SARS
Co-V同为RNA病毒，在侵入细胞的机制上有某些类似之处，因此在SARS的防治中可以借鉴HIV的研究成果，故CMBI全文转载NEJM最新综述，供研究参考。
- Our Strategies for Fighting
Severe Acute Respiratory Syndrome (SARS)(Am J Respir Crit
Care Med－5.28)
- Clinical course and management
of SARS in health care workers in Toronto: a case series(CMAJ－5.28)
- SARS冠状病毒多聚酶基因临床检测方法的建立(第一军医大学学报－5)
- 反转录巢式PCR方法检测SARS冠状病毒(第一军医大学学报－5)
- Anaesthesia and SARS(Br
J Anaesth－5.26)
- Modeling the SARS
Epidemic(Science－5.23)
- Transmission Dynamics
of the Etiological Agent of SARS in Hong Kong: Impact of Public
Health Interventions(Science－5.23)
- Transmission Dynamics
and Control of Severe Acute Respiratory Syndrome(Science－5.23)
- Severe Acute Respiratory Syndrome: Radiographic
Appearances and Pattern of Progression in 138 Patients(Radiology－5.20)
- SARS: Status of the
outbreak and lessons for the immediate future (WHO－5.20)
- Preventing local transmission
of SARS : lessons from Singapore(MJA－5.19)
- Lung pathology of
fatal severe acute respiratory syndrome(Lancet－5.16)
- A multicentre collaboration
to investigate the cause of severe acute respiratory syndrome(Lancet－5.16)
- A new vision for human security(Lancet－5.16)
- Atypical presentations of
SARS(Lancet－5.16)
- The expanding role of common
respiratory viruses in human disease(JMM－5.16)
- Five postulates for resolving
outbreaks of infectious disease(JMM－5.16)
- SARS-Associated Coronavirus(NEJM－5.15)
- Managing SARS amidst Uncertainty(NEJM－5.15)
- SARS and Carlo Urbani(NEJM－5.15)
- SARS, the Internet, and the Journal(NEJM－5.15)
- Radiologic Manifestations
of Severe Acute Respiratory Syndrome(NEJM－5.15)
- The Use of Corticosteroids
in SARS(NEJM－5.15)
- Aetiology: Koch's postulates
fulfilled for SARS virus(Nature－5.15)
- Gene patents and the public
good(Nature－5.15)
- Treatment of severe acute
respiratory syndrome with convalescent plasma(HKMI)
- Severe acute respiratory
syndrome in a doctor working at the Prince of Wales Hospital(HKMI)
- Coronavirus Main
Proteinase (3CLpro) Structure: Basis for Design of
Anti-SARS Drugs(Science－5.13)
- Development
of a standard treatment protocol for severe acute respiratory
syndrome(Lancet－5.10)
- Coexisting with viruses(CURRENT
SCIENCE－5.10)
- ICU management of severe
acute respiratory syndrome(Intensive Care Med－5.9)
- Comparative full-length
genome sequence analysis of 14 SARS coronavirus isolates and common
mutations associated with putative origins of infection(Lancet－5.9)
- Comparative analysis of
the SARS coronavirus genome: a good start to a long journey(Lancet－5.9)
- Clinical progression and
viral load in a community outbreak of coronavirus-associated SARS
pneumonia - a prospective study(Lancet－5.9)
- SARS Treatment Protocol In Hong
Kong(Lancet coming issue－5.9)
- Thin-Section CT of Severe Acute Respiratory
Syndrome: Evaluation of 73 Patients Exposed to or with the Disease(Radiology－5.8)
- Epidemiological
determinants of spread of causal agent of severe acute respiratory
syndrome in Hong Kong(Lancet－5.7)
- Clinical
Features and Short-term Outcomes of 144 Patients With SARS in
the Greater Toronto Area(JAMA－5.7)
- Severe Acute Respiratory
Syndrome - Providing Care in the Face of Uncertainty(JAMA－5.7)
- Severe Acute Respiratory
Syndrome (SARS) and Coronavirus Testing—United States(JAMA－5.7)
- 计算机分析SARS病毒可能含有Caveolin结合区(SARS
coronavirus proteins may contain caveolin binding sites)(北京大学人类疾病基因研究中心－5.7)
- SARS: Fear of global pandemic(Mol
Ther－5.7)
- The
Series Analysis of SARS Coronavirus Genome and Proteins(CMBI,
since 4.26)
- First data on stability and resistance
of SARS coronavirus compiled by members of WHO laboratory network(WHO－5.4)
- Prospective study of the clinical
progression and viral load of SARS associated coronavirus pneumonia
in a community outbreak(WHO－5.4)
- WHO collaborative multi-centre
research project on Severe Acute Respiratory Syndrome (SARS) diagnosis(WHO－5.4)
- SARS:experience at Prince of Wales Hospital,
Hong Kong(Lancet－5.4)
- Aminopeptidase N inhibitors and SARS(Lancet－5.4)
- Effectiveness of precautions against droplets
and contact in prevention of nosocomial transmission of severe
acute respiratory syndrome (SARS)(Lancet－5.4)
- Haemorrhagic-fever-like changes and normal
chest radiograph in a doctor with SARS(Lancet－5.4)
- Will SARS hurt the world’s poor?(Lancet－5.4)
- A complete sequence and comparative
analysis of strain (BJ01) of the SARS-associated virus(Chinese
Science Bulletin－5.3)
- Solid response to SARS almost(Nature
Medicine－5.3)
- Case Definitions
for Surveillance of SARS(WHO－6.27)update
- Use of laboratory methods for
SARS diagnosis(WHO－5.3)
- Sampling for SARS diagnostic tests(WHO－5.3)
- SARS Laboratory diagnostic tests(WHO－5.3)
- SARS may have peaked in Canada, Hong Kong,
and Vietnam (BMJ－5.3)
- Characterization of a Novel
Coronavirus Associated with Severe Acute Respiratory Syndrome(Science－5.2)
- The Genome Sequence of the SARS-Associated
Coronavirus (Science－5.2)
- Hungry for Details, Scientists
Zoom In on SARS Genomes (Science－5.2)
- Virus-encoded proteinases and
proteolytic processing in the Nidovirales(Journal of General
Virology－5.2)--编者按：Nidovirales包括Coronaviridae和Arteriviridae，其基因组的复制、转录、翻译、酶解等许多生物学过程的研究都已经十分清楚，这对我们研究SARS病毒有许多借鉴之处，特此全文转载，供研究参考。
- Lessons from SARS(CMAJ－5.2)
- SARS, lay epidemiology,
and fear(Lancet－5.2)
- The war Against An Unknownpathogen-Rising
To The Sars Challenge(Can Commun Dis Rep－5.1)
- The
Preliminary Analysis of the Mutation of SARS Genes' Sequences
(CMBI－5.1)
- The
Preliminary Analyze the structure and function of the putative
spike protein of SARS virus (CMBI－5.1)
- The Preliminary
Analysis of SARS Proteins' Sequences (III)- CMBI(CMBI－5.1)
- The Preliminary
Analysis of SARS Proteins' Sequences (II)- CMBI(CMBI－5.1)
- The Preliminary Analysis
of SARS Proteins' Sequences (I) - CMBI(CMBI－4.29)
- SARS冠状病毒预测蛋白的种系进化分析(北京大学人类疾病基因研究中心－5.1)
- An appropriate response
to SARS(Lancet Infectious Diseases－5.1)
- Genetic Variability: The
Key Problem in the Prevention and Therapy of RNA-Based Virus Infections(Medicinal
Research Reviews－4.29)
- SARS病毒的背景和初步分析(BioSino－4.29)
- Clinical presentations and outcome of
severe acute respiratory syndrome in children(Lancent－4.29)
- SARS临床诊治现状 － 钟南山(中国医学论坛报－4.29)
- Control Measures for Severe Acute
Respiratory Syndrome (SARS) in Taiwan (CDC－4.28)
- Coronaviruses - the cause
of SARS(Principles of Molecular Virology－4.27)
- SARS Coronavirus Genome
Preliminary Analysis - CMBI(CMBI－4.26)
- WHO biosafety guidelines for handling
of SARS specimens(WHO－4.26)
- 电镜观察从非典型肺炎患者尸检标本中发现衣原体样和冠状病毒样颗粒(中华医学杂志－4.25)
- 重症急性呼吸综合征病例尸解肺组织中新型冠状病毒部分聚合酶基因的序列测定(军事医学科学院院刊－4.25)
- Identification and containment
of an outbreak of SARS in a community hospital(CMAJ－4.25)
- Infectious History(Science－4.25)
- Modelers Struggle to Grasp Epidemic's
Potential Scope(Science－4.25)
- The other war(BMJ－4.25)
- Time to show unity against
SARS(BMJ－4.25)
- How popular perceptions of
risk from SARS are fermenting discrimination(BMJ－4.25)
- Severe acute respiratory syndrome (SARS)
and coronavirus testing--United States, 2003(CDC-MMWR－4.24)
- Influenza-virus-induced signaling cascades:
targets for antiviral therapy?(TRENDS in Molecular Medicine－4.24)
- Rhinovirus and Coronavirus Infection-Associated
Hospitalizations among Older Adults(J. of Infectious Diseases－4.24)
- Improving the care for patients
with acute severe respiratory disease(THORAX－4.24)
- Severe Acute Respiratory Syndrome
(SARS) in Singapore: Clinical Features of Index Patient and Initial
Contacts (CDC－4.23)
- Current research on respiratory viral
infections(Antiviral Research－4.23)
- The SARS epidemic: lessons
for Australia(MJA－4.21)
- The plague within: an Australian
doctor’s experience of SARS in Hong Kong(MJA－4.21)
- Outbreak of severe acute respiratory syndrome
in Hong Kong Special Administrative Region: case report(BMJ－4.19)
- Severe acute respiratory syndrome revisited(BMJ－4.19)
- Emerging stronger from the China crisis(Lancet－4.19)
- Treatment of severe acute
respiratory syndrome with convalescent plasma (Hong Kong
Med J－4.17)
- Severe acute respiratory
syndrome in a doctor working at the Prince of Wales Hospital(Hong
Kong Med J－4.17)
- Editorial:The race to outpace severe acute
respiratory syndrome (SARS)(CMAJ－4.17)
- SARS update(CMAJ－4.17)
- Containing a new infection with new technology:
a Web-based response to SARS(CMAJ－4.17)
- Advancing HIV Prevention and Severe
Acute Respiratory Syndrome(SARS)(CDC－4.17)
- The immediate psychological and occupational
impact of the 2003 SARS outbreak in a teaching hospital(CMAJ－4.16)
- Ribavirin in the treatment of SARS: A
new trick for an old drug?(CMAJ－4.16)
- SARS: the struggle for containment(CMAJ－4.16)
- Coronavirus never before seen in
humans is the cause of SARS(WHO－4.16)
- PCR primers for SARS developed
by WHO Network Laboratories (WHO－4.15)
- Preliminary Clinical Description
of Severe Acute Respiratory Syndrome(Can Commun Dis Rep－4.15)
- Epidemiology, Clinical Presentation
And Laboratory Investigationof Severe Acute Respiratory Syndrome
(Sars) In Canada,March 2003(Can Commun Dis Rep－4.15)
- SARS Associated
Virus Genome Sequencing Project(Canada's Michael Smith
Genome Center－4.14)
- Nucleotide Sequence of Human
Coronavirus, CoV-SARS(US CDC－4.13)
- Coronavirus Protein Analysis
Phylogenetic Trees(USCDC－4.13)
- Identification of a Novel Coronavirus in
Patients with Severe Acute Respiratory Syndrome(NEJM－4.10)
- A Novel Coronavirus Associated with Severe
Acute Respiratory Syndrome(NEJM－4.10)
- Coronavirus as a possible cause of severe
acute respiratory syndrome(LANCET－4.8)
- Novel coronavirus and severe acute respiratory
syndrome(LANCET－4.08)
- Guideline on management of severe acute
respiratory syndrome(LANCET－4.08)
- A Major Outbreak of Severe Acute Respiratory
Syndrome in Hong Kong(NEJM－4.07)
- A Cluster of Cases of Severe Acute Respiratory
Syndrome in Hong Kong(NEJM－3.31)
- Identification of Severe Acute Respiratory
Syndrome in Canada(NEJM－3.31)
|
|
